The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Research & Development
 
Leadership - Caelum Biosciences
Stock and Other Ownership Interests - Caelum Biosciences
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen
Speakers' Bureau - Takeda
 
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
 
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
Research Funding - Amgen; Celgene
 
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Takeda
Research Funding - Amgen; Janssen; Novartis; Takeda
Efficacy of daratumumab in combination with lenalidomide plus dexamethasone (DRd) or bortezomib plus dexamethasone (DVd) in relapsed or refractory multiple myeloma (RRMM) based on cytogenetic risk status.
 
Katja C. Weisel
No Relationships to Disclose
 
Jesus San Miguel
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; CELGENE; Janssen-Cilag; MSD; Novartis; Takeda
 
Gordon Cook
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Takeda
Speakers' Bureau - Celgene; Janssen; Takeda
Research Funding - Celgene; Takeda
Travel, Accommodations, Expenses - Janssen; Takeda
 
Merav Leiba
No Relationships to Disclose
 
Kenshi Suzuki
Honoraria - Celgene; Janssen; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Takeda
 
Shaji Kumar
Honoraria - Kesios Therapuetics; Noxxon Pharma; Skyline Diagnostics
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
 
Michele Cavo
No Relationships to Disclose
 
Herve Avet-Loiseau
No Relationships to Disclose
 
Hang Quach
No Relationships to Disclose
 
Vania Hungria
No Relationships to Disclose
 
Suzanne Lentzsch
No Relationships to Disclose
 
Roman Hajek
No Relationships to Disclose
 
Pieter Sonneveld
Honoraria - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Takeda
Research Funding - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Takeda
 
Kaida Wu
Employment - Janssen
 
Xiang Qin
No Relationships to Disclose
 
Christopher Chiu
Employment - Janssen
 
David Soong
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Ming Qi
Employment - Janssen
 
Jordan Mark Schecter
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Meletios A. Dimopoulos
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genesis Pharmaceuticals; Janssen-Cilag; Novartis; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
Research Funding - Amgen (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Amgen; Genesis Pharmaceuticals; Janssen-Ortho